The QualityStocks Daily Monday, August 1st, 2022

Today's Top 3 Investment Newsletters

MarketClub Analysis(QRTEB) $18.2300 +326.93%

QualityStocks(CYAD) $2.4500 +43.27%

Schaeffer's(TBLT) $8.6400 +21.86%

The QualityStocks Daily Stock List

TherapeuticsMD (TXMD)

MarketClub Analysis, MarketBeat, InvestorPlace, The Street, BUYINS.NET, StockMarketWatch, StreetInsider, Schaeffer's, INO.com Market Report, Barchart, Marketbeat.com, Wall Street Resources, StockOodles, QualityStocks, TraderPower, Kiplinger Today, ProTrading Research, Wealth Insider Alert, TradersPro, StreetAuthority Daily, CRWEWallStreet, CRWEFinance, BestOtc, CRWEPicks, Hit and Run Candle Sticks, INO Market Report, DrStockPick, Investing Futures, InvestorsUnderground, PennyToBuck, StockHotTips, Street Insider, TopPennyStockMovers, Trades Of The Day, Trading Concepts and PennyOmega reported earlier on TherapeuticsMD (TXMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TherapeuticsMD Inc. (NASDAQ: TXMD) (FRA: 29T) is a pharmaceutical firm that is engaged in the development and commercialization of over-the-counter products as well as generic and branded prescriptions for women.

TherapeuticsMD Inc. has its headquarters in Boca Raton, Florida and was founded by Brian A. Bernick and Robert G. Finizio in 2008. The firm sells its prescription prenatal hormone therapy and vitamin drug products to retail pharmacy and wholesale distributors. TherapeuticsMD Inc. operates in the United States.

TherapeuticsMD uses its technology, dubbed SYMBODA, to develop advanced hormone therapy pharmaceuticals that have been designed to reduce the symptoms of and alleviate the health risks that arise from hormone deficiencies related to menopause.

TherapeuticsMD Inc. has developed a ring-shaped contraceptive vaginal system known as ANNOVERA, which is a bio-identical hormone therapy developed to help treat moderate-to-severe vasomotor symptoms dubbed BIJUVA and IMVEXXY, which has been indicated for treating moderate-to-severe dyspareunia. The firm’s preclinical projects include transdermal patch product candidates dubbed TX-0008HR and TX-00THR; a progesterone and estradiol transdermal cream known as TX-006HR; a progesterone transdermal cream called TX-005HR and an oral estradiol and progesterone formulation christened TX-009HR. TherapeuticsMD Inc. also manufactures and distributes generic and branded prescription prenatal vitamins under the BocaGreenMD, vitaMedMD, vitaPearl and vitaTrue brands.

TherapeuticsMD Inc.’s IMVEXXY product was recently approved by Health Canada as a treatment for postmenopausal dyspareunia, which has been indicated for postmenopausal women who experience pain before, during or after sex. Around 75% of women have painful intercourse at some time and the product, which is marketed in Canada as well as the U.S. helps alleviate these symptoms as well as the resultant pain.

TherapeuticsMD (TXMD), closed Monday's trading session at $8.51, up 36.5971%, on 6,440,920 volume. The average volume for the last 3 months is 6.441M and the stock's 52-week low/high is $1.99/$51.00.

Reed’s (REED)

Wall Street Resources, QualityStocks, MarketBeat, Stock Guru, MissionIR, SmarTrend Newsletters, StreetInsider, TraderPower, SmallCap Network, Momentum Traders, StockMarketWatch, The Street, PennyTrader.com, Penny Stock Pros, PennyStocks24, StreetAuthority Daily, Promotion Stock Secrets, Stock Traders Chat, PennyStockClub, BullRally, BUYINS.NET, InvestorPlace, Trades Of The Day, TradersPro, StocksImpossible, OTCBB Journal, Penny Stock Advice, Zacks, Penny Stocks Expert, SmallCapNetwork, Stock News Now, The Stock Scout, SmallCapVoice, Barchart, Tiny Gems and Penny Detectives reported earlier on Reed’s (REED), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Reed's Inc. (NASDAQ: REED) is engaged in the development, manufacture and sale of non-alcoholic beverages, candies and kombucha in South America, Australia, Europe, Asia, Canada and the United States.

The firm has its headquarters in Norwalk, Connecticut and was incorporated in June 1987 by Christopher J. Reed. Prior to its name change in 2001, the firm was known as Original Beverage Corporation.

The company, which operates in the craft specialty foods industry, sells its products to restaurants, on-premise bars, industrial cafeterias, liquor stores, drug and convenience stores, club stores, mass merchants, grocery store chains, gourmet and natural food retailers through independent distributor partners and other distributors, as well as directly. Its products include craft sodas, Reed’s Ginger candy and Flying Cauldron Butterscotch beer.

The enterprise also owns a private label business. This is in addition to manufacturing, licensing, marketing and selling several product lines, such as Real Cola, which includes zero diet sodas; China colas and Culture club kombucha; and Reed’s Ginger brews like Dr. Better, Cream sodas and Virgil’s root beer. It produces these carbonated beverages at different facilities, including one known as The Brewery, which is located in Los Angeles, California.

The company, which has been expanding their distribution across all channels, recently announced that they had gotten into an expanded distribution agreement with CVS Health Corp. This move will allow Virgil’s and Reed’s beverages to be stocked at CVS Pharmacy locations across the U.S. Increased availability is bound to increase sales, which will in turn boost the company’s revenue.

Reed’s (REED), closed Monday's trading session at $0.2049, up 30.0127%, on 1,962,507 volume. The average volume for the last 3 months is 1.891M and the stock's 52-week low/high is $0.1351/$0.81.

Aethlon Medical (AEMD)

Tip.us, Investor Ideas, QualityStocks, StockMarketWatch, Red Chip, Streetwise Reports, OTCPicks, PennyStocks24, BUYINS.NET, MarketClub Analysis, MarketBeat, TraderPower, FeedBlitz, TradersPro, MicroCap Gems, AllPennyStocks, SmallCapVoice, StreetInsider, RedChip, Clutch Investments, Pennybuster, PricelessPennyStocks, PennyStockRumors.net, Stock Castle, Trading Concepts, BestStockChoice, TopPennyStockMovers, The Online Investor, DrStockPick, Faisam Trader, StockBlogs, INO Market Report, PennyOmega, Investing Futures, InvestorPlace, InvestorsUnderground, SmallCapStockPlays, SmallCap Network, Nebula Stocks, PennyTrader Publisher, WallStreet Advisors, Actual Gains and Investing Daily reported earlier on Aethlon Medical (AEMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aethlon Medical Inc. (NASDAQ: AEMD) (FRA: EJU) is a medical technology firm that is engaged in the development of products that help in diagnosing and treating organ and life threatening ailments in the U.S.

The firm has its headquarters in San Diego, California and was incorporated in May 1998 by James A. Joyce. It is a part of the scientific and technical instruments manufacturing industry and operates in the health care industry, under the medical equipment and devices sub-industry.

The company is party to a collaboration agreement with the University of Pittsburgh which entails research on neck and head cancers. It operates through the ESI and Aethlon segments. The latter segment is involved in diagnostic business activities while the former segment deals with therapeutic business activities.

The enterprise offers a platform that develops medical equipment to target the selective removal of ailment-promoting particles from an individual’s circulatory system, known as ADAPT. Its product pipeline is made of an exosomal biomarker candidate known as TauSome, which diagnoses chronic traumatic encephalopathy in people. In addition to this, the enterprise also develops a clinical-stage immunotherapeutic device known as the Aethlon Hemopurifier, which removes life-threatening viruses and exosomes from the body’s circulatory system. These exosomes aid in the progression of infectious viral pathogens like Hepatitis C and HIV as well as cancer.

The firm recently published case studies of 2 coronavirus patients who were treated with its Hemopurifier, with its CEO noting that their device may play a crucial role in filtering out exosomes, adding that their device was able to clear the SARS-CoV-2 virus from both patients’ bloodstream. The device’s success in treating both patients may bring in more investors into the firm and push share prices higher.

Aethlon Medical (AEMD), closed Monday's trading session at $1.38, up 38%, on 76,216,795 volume. The average volume for the last 3 months is 76.217M and the stock's 52-week low/high is $0.88/$5.9899.

Celyad Oncology SA (CYAD)

StockMarketWatch, TraderPower, MarketBeat, Streetwise Reports, Schaeffer's, MarketClub Analysis, Zacks, Wealth Insider Alert, Stock Gumshoe and QualityStocks reported earlier on Celyad Oncology SA (CYAD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Celyad Oncology SA (NASDAQ: CYAD) (FRA: 1C0) is a clinical-stage biopharmaceutical firm that is engaged in discovering and developing CAR-T cell-based therapies for treating cancer.

The firm has its headquarters in Mont-Saint-Guibert, Belgium and was incorporated in 2007, on July 24th by Christian Homsy, William Wijns and Michel Lussier. Prior to its name change in June 2020, the firm was known as Celyad SA. It serves consumers across the globe.

The company operates through its immune-oncology and cardiology operating segments. It is party to license, research and development collaboration agreements with Horizon Discovery Group Plc, which entails the use of its shRNA technology to develop a second non-gene-edited allogeneic platform. The company is also party to another licensing agreement with Novartis International, which involves its allogeneic CAR-T cell patents.

The enterprise’s product pipeline includes its dual specific CAR-T candidate dubbed CYAD-231, which targets natural killer group 2D ligands; a shRNA based allogeneic CAR-T candidate dubbed CYAD-221, which is indicated for the treatment of B-cell malignancies; and an allogeneic CAR-T candidate to treat solid tumors. It also develops an autologous CAR-T therapy known as CYAD-02, which is in a phase I clinical trial developed to treat solid tumors and hematological malignancies; a shRNA-based allogeneic CAR-T candidate dubbed CYAD-211, which is undergoing a phase 1 clinical trial and is indicated for the treatment of refractory/relapsed multiple myeloma. In addition to this, the enterprise develops another allogeneic CAR-T candidate known as CYAD-101, which is undergoing a phase 1 clinical trial evaluating its effectiveness in treating metastatic colorectal cancer.

The firm is focused on developing new technologies to advance allogeneic CAR-T therapies. It plans to announce various clinical updates that’ll advance the progress of its lead programs. This may encourage more investments into the firm, which will be good for its growth.

Celyad Oncology SA (CYAD), closed Monday's trading session at $2.45, up 43.2749%, on 7,410,633 volume. The average volume for the last 3 months is 7.384M and the stock's 52-week low/high is $1.51/$5.32.

KORE Group Holdings (KORE)

OTCPicks, SmallCapVoice, PennyTrader Publisher, Franks Penny Stocks, Penny stock Profitz, MarketBeat, FeedBlitz, PennyToBuck, DrStockPick, CRWEWallStreet, CRWEPicks, CRWEFinance, AllPennyStocks, BestOtc, PennyOmega, Wise Penny Stocks, Micro Cap Momentum, StockHotTips, Whisper from Wall Street, WallstreetsHotteststocks, Stock Market News Alert, Bold Stocks, Trade of the Week, TopStockAnalysts, TheStockAdvisors, Super Stock Investor, Penny Stocks Pushers, Stockupticks, Pinkinvestors, Millennium-Traders, Oakshire News Bulletin, Otcstockexchange, Partner Investor Alerts, Stock Guru, Stock Fortune Teller, QualityStocks and StreetAuthority Financial reported earlier on KORE Group Holdings (KORE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

KORE Group Holdings Inc. (NYSE: KORE) is a holding firm that is engaged in the provision of IoT (Internet of Things) solutions and services.

The firm has its headquarters in Alpharetta, Georgia and was incorporated in 2002. It operates as part of the telecom services industry, under the communication services sector. The firm serves consumers around the world.

The company is focused on empowering organizations to improve business and operational results by simplifying IoT’s complexity. Its IoT platform is delivered in partnership with mobile network operators. It operates through its subsidiaries, generating revenues from IoT devices (IoT solutions), IoT connectivity (SIMs), IoT solutions services and IoT connectivity services.

The enterprise provides secure wireless connectivity to fixed and mobile devices. It offers managed and professional services, location-based services, advanced connectivity services and device solutions used to develop and support IoT applications and solutions for the machine-to-machine market. The enterprise’s products include PositionLogic platform, the SecurityPro platform, KORE One, ConnectivityPro, KORE eSIM, IoT security location based services, IoT device management services, Connectivity Enablement as a Service and IoT Connectivity as a Service. The enterprise serves consumers in a range of industries, including industrial/manufacturing, communication services, asset management, vehicle and fleet management and healthcare.

The company was recently named the 2022 Global Competitive Strategy Leader in the IoT professional services industry. This award highlights its strengths in innovation and will open the company up to numerous growth opportunities, which will in turn, positively influence its revenues and investments.

KORE Group Holdings (KORE), closed Monday's trading session at $2.7, up 1.5038%, on 65,829 volume. The average volume for the last 3 months is 65,729 and the stock's 52-week low/high is $2.51/$9.50.

Societal CDMO (SCTL)

We reported earlier on Societal CDMO (SCTL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Societal CDMO Inc. (NASDAQ: SCTL) (FRA: RAH) is a contract development and manufacturing organization that is focused on conducting research, developing, manufacturing and packaging for a range of therapeutic dosage forms.

The firm has its headquarters in Exton, Pennsylvania and was incorporated in 2007, on November 15th by Thomas F. Henwood and Geraldine A. Henwood. Prior to its name change in March 2022, the firm was known as Recro Pharma Inc. It operates as part of the drug manufacturers-specialty and generic industry, under the healthcare sector. The firm serves consumers in the United States and internationally.

The company is primarily focused on solving a range of manufacturing issues, in addition to being involved in pre-investigational new drug development to commercial manufacturing and packaging for an extensive range of therapeutic dosage forms, with a principal focus in the area of small molecules. It carries out its operations in San Diego, California and Gainesville, Georgia.

The enterprise offers commercial and clinical manufacturing, end-to-end regulatory support, therapeutic development, lyophilization, aseptic fill/finish, packaging and logistics services to the international pharmaceutical market. It also has experience handling DEA controlled substances and has the ability to deliver on its clients’ manufacturing and pharmaceutical development projects.

The company has entered into a new agreement with Lannett Co., which will involve marketing Verelan SR and Verapamil products. This move will help extend the company’s reach and generate additional revenues while also encouraging more investments into the company, which will be good for its growth.

Societal CDMO (SCTL), closed Monday's trading session at $0.92, up 2.2222%, on 21,483 volume. The average volume for the last 3 months is 21,483 and the stock's 52-week low/high is $0.62/$2.6655.

Integra Resources (ITRG)

We reported earlier on Integra Resources (ITRG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Integra Resources Corp (NYSE American: ITRG) (CVE: ITR) (FRA: IRVA) is a mineral resources firm that is focused on acquiring, exploring for and developing mineral properties in the Americas.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1997, on April 15th. Prior to its name change in August 2017, the firm was known as Mag Copper Ltd. It operates as part of the other precious metals and mining industry, under the basic materials sector. The firm serves consumers in North America.

The company explores for gold, base metals and other mineral commodities, with a primary focus on the development of the DeLamar project. It has optioned the War Eagle project from an Ely Gold Royalties Inc. Subsidiary called Nevada Select.

The enterprise’s DeLamar project is made up of the Florida Mountain and DeLamar silver and gold deposits, located in the mining district of Owyhee County, in the southwestern region of Idaho. The DeLamar project, which is situated about 160 km from Boise, comprises of about 16 tax parcels that include 5300 acres of unpatented and patented claims and more than 4000 acres of leased land. On the other hand, its Florida mountain project is a low-sulphidation silver-gold epithermal system.

The firm recently announced its new strategy to reduce its operating costs and capital requirements and expand leachable resource at its DeLamar project. This strategy will help the firm achieve its strategic objectives while also bringing in additional revenues and investments, which will help create shareholder value.

Integra Resources (ITRG), closed Monday's trading session at $0.705, up 3.6612%, on 136,653 volume. The average volume for the last 3 months is 136,653 and the stock's 52-week low/high is $0.6399/$3.11.

Snow Lake Resources (LITM)

MarketClub Analysis reported earlier on Snow Lake Resources (LITM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snow Lake Resources Ltd (NASDAQ: LITM) is a natural resource exploration firm that is focused on exploring for and developing mineral resources.

The firm has its headquarters in Winnipeg, Canada and was incorporated in 2018. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers globally, with a focus on Australia and Canada.

The company specializes in acquiring, exploring for and developing lithium projects. It is committed to operating a fully sustainable and renewable lithium mine which can deliver completely carbon neutral, traceable and zero harm products to the battery and electric vehicle market globally. The company operates as a Nova Minerals Ltd subsidiary and conducts exploration efforts through its Snow Lake Crowduck and Snow Lake Exploration subsidiaries.

The enterprise is primarily carrying out exploration for lithium on its Thompson Brothers Lithium property. This property comprises of about 38 contiguous mineral claims which cover almost 5600 hectares located near central Manitoba, Canada. It is located about 20km east of the Snow Lake mining community. The property is made up of two lithium-based spodumene pegmatite clusters known as the Sherritt Gordon and the Thompson Brothers pegmatite dykes. This property delivers mined and processed lithium products to the battery market.

The firm is collaborating with Epiroc Canada Inc. to assist with the commercial and technical design of the first fully electric lithium mine globally. This move will open it up to new growth opportunities, which will help create value for its shareholders and bolster its overall growth.

Snow Lake Resources (LITM), closed Monday's trading session at $2.53, off by 2.3166%, on 62,112 volume. The average volume for the last 3 months is 62,022 and the stock's 52-week low/high is $2.12/$18.42.

Astra Space (ASTR)

Schaeffer's, MarketClub Analysis, The Street, MarketBeat, Trades Of The Day, InvestorPlace and Daily Trade Alert reported earlier on Astra Space (ASTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Astra Space Inc. (NASDAQ: ASTR) is a technology firm that is focused on designing, testing, manufacturing, launching, operating and providing space products and services.

The firm has its headquarters in Alameda, California and was incorporated in 2016 by Randy Russell and Craig McCaw. Prior to its name change, the firm was known as Holicity Inc. It operates as part of the aerospace and defense industry, under the industrials sector. The firm serves consumers in the United States.

The company’s mission is to improve life on earth from space by getting its clients’ satellites to their desired orbits on their schedules. It is now offering dedicated launch services for payloads up to 500km mid-inclination low Earth orbit. The company operates its launches from Cape Canaveral Space Force Station in Cape Canaveral, Florida and Pacific Spaceport Complex in Kodiak, Alaska.

The enterprise offers space products based on the client’s needs for a satellite launch. Its space services include all aspects of hosted satellite and constellation services, including hosting client payloads onto its spacecraft. The enterprise’s system comprises of mobile ground infrastructure and a small launch vehicle that can fit inside a standard shipping container for deployment where its spaceports are located globally.

The firm recently announced its latest financial results, with its CEO noting that they remained focused on accelerating consumer adoption of its space technology products, growth in its consumer pipeline and furthering its vision. This will positively influence the firm’s revenues and investments and bolster its growth.

Astra Space (ASTR), closed Monday's trading session at $1.46, up 2.0979%, on 1,272,132 volume. The average volume for the last 3 months is 1.272M and the stock's 52-week low/high is $1.19/$13.58.

RIOT Blokchain Inc. (RIOT)

Schaeffer's, MarketClub Analysis, StocksEarning, InvestorPlace, StockMarketWatch, MarketBeat, TradersPro, Market Intelligence Center Alert, The Street, Zacks, QualityStocks, Kiplinger Today, TraderPower, The Online Investor, BUYINS.NET, Trades Of The Day, Daily Trade Alert, StockRockandRoll, Trading Tips, PennyStockLocks, Penny Stock 101, StreetAuthority Daily, Market Intelligence Center, Investors Alley, InvestorsUnderground, StockEarnings, Money Morning, Promotion Stock Secrets, The Daily Market Alert, StreetInsider and TopPennyStockMovers reported earlier on RIOT Blokchain Inc. (RIOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Most experts will say that there have been three generations of the web: Web 1.0, Web 2.0 and Web 3.1. The first iteration of the internet is also referred to as the read-only web, the second is the participative social web and the third version of the internet is the “read, write, execute web.” These three generations have been spread out over the past three decades or so since the internet was invented.

Just as there has been three generations of the web, blockchain technology has also evolved through three different eras, albeit over a much shorter timeline. But while the third iteration of the internet, Web 3.0, is still in its infancy, the three generations of blockchain have distinct and established objectives. So what do we mean by “generations” of blockchain?

Since blockchain is fully reliant on technology, generations are influenced by evolutions in the underlying technology. This usually consists of unlocked uses and new features that increase the technology’s adoption. Let’s look at how the three generations of blockchain technology have evolved.

Cryptocurrency was the first generation, and Bitcoin was undoubtedly the catalyst that led to the popularity of digital tokens. The craze started when Satoshi Nakamoto published the Bitcoin whitepaper more than 10 years ago. Blockchain was only used to facilitate cryptocurrency transactions in its early days, specifically Bitcoin, which was meant to be an alternative to centralized fiat currencies.

Blockchain could solve the problem of centralization thanks to its decentralized nature, and it was seemingly introduced at just the right moment. Soon after the 2008 recession, plenty of people lost trust in the financial system and adopted Bitcoin.

Smart Contracts (Ethereum). The introduction of Ethereum, currently the second most prominent cryptocurrency, defined the beginning of the second generation of blockchain. Ethereum introduced the concept of smart contracts, which refers to blockchain-based contracts that are triggered automatically once all requirements are met.

This smart-contract technology allowed blockchain to evolve into a digital ecosystem, giving developers a chance to launch their own crypto applications and projects using smart contract tech. Ethereum was essentially a platform for developers to expand upon, and it enabled the trustless, decentralized nature that allowed users to enter into agreements without the mediation of a governing body.

Smart Everything (Cardano, Polkadot, Ethereum). As Bitcoin, Ethereum and second-generation blockchains became more popular and attracted more users, they ran into scalability issues, became more sluggish and increased transaction fees significantly. This has led to the emergence of newer projects that have solved most scalability challenges and have nominal transaction fees as well as super-fast processing speeds. These blockchains have found ways to scale up without compromising security or decentralization.

Furthermore, newer blockchains are much more energy efficient and are interoperable, meaning they can interact with each other, something Bitcoin and Ethereum couldn’t do. These improved features have made blockchain even more mainstream, leading to increased interest and investment in blockchain projects by major corporations and institutions.

As entities such as RIOT Blokchain Inc. (NASDAQ: RIOT) deepen their reach, the adoption of blockchain technology is likely to grow in different sectors and industries.

RIOT Blokchain Inc. (RIOT), closed Monday's trading session at $7.33, up 0.136612%, on 13,572,126 volume. The average volume for the last 3 months is 13.572M and the stock's 52-week low/high is $4.02/$46.28.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, MarketClub Analysis, Schaeffer's, Kiplinger Today, QualityStocks, MarketBeat, StockMarketWatch, StreetInsider, StocksEarning, TradersPro, The Street, Trades Of The Day, Daily Trade Alert, TopPennyStockMovers, TraderPower, BUYINS.NET, Zacks, Wealth Insider Alert, Early Bird, Jason Bond, Cabot Wealth, InvestorsUnderground, PoliticsAndMyPortfolio, StockOodles, The Online Investor, Marketbeat.com, Profitable Trader Authority, Stock Beast, Wealth Daily, Energy and Capital, The Best Newsletters, Daily Market Beat and The Wealth Report reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The race to electrify the road transport network is on. The Biden administration has provided $5 billion for the development of a nationwide network of public electric vehicle chargers, and automakers have pledged to spend billions of dollars developing new electric vehicle models over the next decade. However, the high prices of most EV models prevent a significant portion of the population from ditching their internal combustion engine (ICE) cars and going electric.

To help offset these costs and reduce the financial burden on buyers, the state of New Jersey will provide millions of dollars in financial incentives to EV buyers. State Governor Phil Murphy announced last week that New Jersey will fork out up to $4,000 to every driver who purchases an electric vehicle as part of wider efforts to reduce reliance on fossil fuel vehicles and fight climate change.

The state would also provide up to $250 to help drivers install private charging stations in their homes, as well as $4 million to be used as incentives for condos and apartment buildings to install charging stations for their residents on-site. In total, Murphy said, the 2022 Clean Energy Fund will provide around $60 million for the electric vehicle incentive program.

Speaking at an event held at Asbury Park, Murphy said that these incentives would encourage more drivers to purchase electric vehicles, especially as prices of the EVs are projected to become equal to comparable fossil fuel vehicles. Vehicles under $45,000 will be eligible for up to $4,000 in incentives while EVs priced from $45,000 to $50,000 will qualify for up to $2,000, the governor’s office said. Only New Jersey residents will be able to receive the incentives.

Another $4 million will be used to incentivize local governments to purchase zero-emission electric cars, with the Murphy administration dedicating $30 million in total to buying electric vehicles. Murphy noted that electric vehicles made up 5% of vehicle sales countrywide and that his administration wanted to help increase that percentage by making it easier for more New Jersey residents to buy electric vehicles.

At the moment, an estimated 65,000 EVs are registered in the state. The Charge Up New Jersey Program, which has provided incentives and contributed to purchasing more than 13,000 EVs in the past two years, is now in its third year. The program previously provided incentives of up to $5,000 for EVs under $55,000, but the incentives were recently reduced to $4,000 to spread out the funding and provide more incentives.

Such incentives are likely to bring the electric vehicles made by companies such as Workhorse Group Inc. (NASDAQ: WKHS) within reach for a lot more motorists, and EV penetration will happen at a faster pace.

Workhorse Group Inc. (WKHS), closed Monday's trading session at $3.5, up 7.0336%, on 6,178,638 volume. The average volume for the last 3 months is 6.179M and the stock's 52-week low/high is $2.11/$11.6277.

Southern Copper Corporation (SCCO)

SmarTrend Newsletters, MarketBeat, InvestorPlace, The Street, Louis Navellier, The Online Investor, Daily Wealth, Daily Trade Alert, The Wealth Report, TopStockAnalysts, Trades Of The Day, StreetAuthority Daily, Marketbeat.com, Zacks, Barchart, Money Morning, TheStockAdvisor, Kiplinger Today, QualityStocks, Schaeffer's, Market Intelligence Center Alert, MarketClub Analysis, Investopedia, Uncommon Wisdom, Top Pros' Top Picks, The Growth Stock Wire, Market Authority, The Stock Enthusiast, Early Bird, ChartAdvisor, TheStockAdvisors, INO.com Market Report, StreetInsider, InvestmentHouse, Investiv, Investing Futures, Greenbackers, Forbes, Investor Update, Dividend Opportunities, CRWEWallStreet, CRWEPicks, CRWEFinance, BestOtc, AllPennyStocks, DrStockPick, StockLockandLoad, Wealth Insider Alert, Wealth Daily, Vantage Wire, TradingMarkets, TradingAuthority Daily, The Tycoon Report, The Trading Report, The Motley Fool, MarketDNA, StockRockandRoll, InvestorGuide, StockHotTips, Profit Confidential, PennyToBuck, PennyOmega, Navellier Growth, Money and Markets, 24/7 Trader, InvestorsObserver Team, InvestorIntel and Streetwise Reports reported earlier on Southern Copper Corporation (SCCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Over the past couple of years, geopolitical events have led to a slowdown in the global economy, starting with COVID in late 2019 and culminating with the Russia-Ukraine war earlier this year. The pandemic significantly impacted supply chains and led to issues, including the global chip shortage, that are still affecting industries to this day, while Russia’s invasion of Ukraine contributed to soaring energy and food prices across the world.

Several other economic factors have caused the dollar to depreciate in value for the past few months, with the greenback dropping in value again after the U.S. Federal Reserve hikes interest rates by 75 basis points last week.

Coupled with supply risks, the weakening dollar contributed to an increase in copper prices last week as well. The weaker dollar made copper a little cheaper for buyers with different currencies, increasing demand for the metal while major producers flagged supply risks that offset demand concerns.

Copper on the London Metal Exchange went up by 15% to reach about $7,590 per ton while the Shanghai Future Exchange’s most popular September copper contract went up by 21% to hit $8,640.85 a ton. The rise in prices came just a day after the dollar weakened as investors anticipated the Fed’s increase interest rates by another 75 basis points. With this recent slump, the dollar has now depreciated in value for four consecutive sessions. Although the Fed’s increasingly hawkish stance is meant to forestall inflation, it has led many experts to fear that the agency may trigger recession instead.

Copper prices have also increased due to a reduction in the global copper supply. Just last week, miners Antofagasta and Vale SA cut their copper production outlook for 2022. Last week, Chinese mining company MMG Ltd 1208.HK also announced that it was suspending its 2022 copper production targets because of a long protest in its Las Bambas Peru mine that had disrupted mining operations and caused the mine’s output to drop by 60%.

Craig Lang, an analyst at CRU, said that these miners have had a hard time meeting the bottom end of their guidance ranges, offsetting some of the slowed demand growth and increasing copper prices.

Although copper prices saw a measurable rise, the prices for the metal have been on a downward spiral for the past few months, dropping by 30% since they hit a high of $10,845 per ton in March 2022.

Leading copper producers such as Southern Copper Corporation (NYSE: SCCO) will be watching market developments closely to see how their short- and medium-term projections may be impacted by this volatility.

Southern Copper Corporation (SCCO), closed Monday's trading session at $47.93, off by 3.755%, on 1,527,689 volume. The average volume for the last 3 months is 1.512M and the stock's 52-week low/high is $44.70/$79.315.

The QualityStocks Company Corner

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has opened a new 16,000-square-foot automotive development center; the center is located in the center of the technology corridor of Irvine, California, and near the Irvine Spectrum Center. According to the announcement, as the company sees continued growth, it is strategically dividing its automotive teams between the new Irvine location and the existing MULN facility in Monrovia. The Irvine Automotive Development Center will house Mullen’s engineering design and development, styling, program management, marketing and finance teams, with Monrovia being home base for the company’s battery, powertrain, thermal and infotainment teams. “This facility is a great addition and the logical next step in the evolution of our corporate footprint as we begin to scale our teams and dedicate more resources to support our EV programs,” said Mullen Automotive CEO and chair David Michery in the press release. “Irvine technology’s hub is a great location for us to anchor our EV team and provides us with the space and potential talent pool to support our growth over the next few years.” To view the full press release, visit https://ibn.fm/1wYox

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $0.8669, up 9.3604%, on 76,880,580 volume. The average volume for the last 3 months is 76.881M and the stock's 52-week low/high is $0.52/$15.90.

Recent News

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

The Drug Enforcement Administration (DEA) recently withdrew a proposal to ban certain psychedelics, stating that it had instead decided to request for an updated review of the psychedelic compounds from the Department of Health and Human Services (DHHS). The DEA had first proposed that the DiPT, 5-MeO-DET, 5-MeO-MiPT, 5-MeO-AMT and 4-OH-DiPTtryptamines be scheduled earlier in the year. Tryptamines are psychedelic and hallucinogenic drugs that cause users to experience hallucinations as well as euphoria. However, after the announcement, the agency faced criticism on the matter and received hundreds of messages opposing the change and asking for a hearing. Through its own administrative court, the DEA decided to hold a hearing on the matter before prohibition could be approved. Following the agency’s recent announcement, however, the hearing, which was set for Aug. 22, 2022, has been called off. This change of heart regarding the plan to ban a handful of psychedelic compounds could signal that the DEA is becoming more responsive to the feedback and sentiments of the scientific community and other stakeholders such as Silo Pharma Inc. (OTCQB: SILO) that would like to see the industry grow under a regulatory framework which addresses public health concerns while allowing industry players to be innovative.

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Monday's trading session at $0.14, up 1.1561%, on 74,954 volume. The average volume for the last 3 months is 74,954 and the stock's 52-week low/high is $0.0892/$0.2489.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), is scaling solutions through the LN. “The company released its first node (US-West) in November 2021, alongside its platform-as-a-service (“PaaS”) offering, https://lqwd.tech. The current capacity of US-West is 6.06271656 BTC (606,271,656 sat/ US$118,154.83); it has over 100 active channels and connected nodes currently operational. Over the last 30 days, US-West has experienced an increase of 0.277324 BTC (+4.79%), an increase of six channels (+5.71%), and a median fee rate of 0.000003 sat. LQwD’s nodes currently operate across 17 countries, but the company’s goal is to expand to 24 by the end of the current quarter,” a recent article reads. “LQwD’s PaaS allows users to manage Lightning Network node hosting and channel management. It is also a liquidity service provider (‘LSP’) for merchants, utilizing globally distributed routing nodes through an easy-to-use API. The interface makes it easier for users to send and receive BTC across the Lightning Network, faster and at lower fees than traditional blockchain transactions. The company hopes to achieve accretive growth by targeting up-and-coming Lighting Network projects and LSPs.” To view the full article, visit https://ccw.fm/yTiBe

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Monday's trading session at $0.113, up 20.6298%, on 18,405 volume. The average volume for the last 3 months is 18,405 and the stock's 52-week low/high is $0.0637/$0.672.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has completed the sale of 1,240 units, with each unit consisting of one 4% senior secured $1,064 ‎principal amount convertible debenture and 16,369 share purchase warrants. The sale, which was resulted in gross proceeds of $1,240,000 for the company, was completed on July 27, 2022. According to the announcement, the principal amount and accrued but unpaid interest on each debenture is ‎convertible into common shares of the company; that conversion is done at the option of the holder at any ‎time following the closing date at a price of ‎$0.065 per common share‎. The company noted that the debentures will mature 24 months from the closing date and will bear interest at a rate of 4% ‎per annum, payable quarterly on the last business day of each calendar quarter. The announcement also noted that all outstanding principal amounts along with all unpaid ‎interest must be repaid at the maturity date. The company also observed that all securities issued in the debenture offering are subject to a hold period of four ‎‎months and one day from the closing date. ‎Delic intends to use the proceeds from the debenture for expansion and general corporate purposes. To view the full press release, visit https://ibn.fm/zXmMb

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Monday's trading session at $0.04915, up 11.959%, on 90,515 volume. The average volume for the last 3 months is 90,515 and the stock's 52-week low/high is $0.03/$0.315.

Recent News

Cub Crafters Inc.

The QualityStocks Daily Newsletter would like to spotlight Cub Crafters Inc.

  • Cub Crafters Inc. looks to take advantage of Regulation A to allow new public investment for scaling the company’s operations and attain the critical goal of continuing to innovate
  • Once qualified to launch its public offering by the SEC, the company will offer its shares at $5 a share, with a minimum investment of $400 per investor
  • CubCrafters looks to bank on the significant increase in backcountry flying, which has, in turn, driven up the demand for its aircraft
  • The company’s management is confident that with this offering, the capital raised will enable it to achieve additional growth, delivering exceptional service and support to the market

There are three primary ways that growing companies can source needed capital. First, enterprises can opt to simply use their retained earnings. Alternatively, they can go with debt capital, often in the form of a traditional loan from financial institutions. The last and most viable option in many cases is to obtain equity capital, which involves selling ownership stakes as shares to investors who, in turn, become stockholders. For equity capital, a business can choose to go one of two ways. On one hand, it can file with the United States Securities and Exchange Commission (“SEC”) for an Initial Public Offering (“IPO”). This requires meeting standard registration requirements before announcing the IPO. On the other hand, they can file for an exemption, specifically a Regulation A (“Reg A”) exemption, allowing them to raise money from the public in securities offerings, usually up to $75 million, with no formal SEC registration (https://ibn.fm/0h5iq). Typically, Regulation A is designed to accommodate smaller companies in earlier stages of development. Many companies have capitalized on this opportunity, with 107 raising approximately $1.5 billion via Regulation A and the amended Regulation A+ between 2015 and 2018 (https://ibn.fm/vVOFc). Cub Crafters, the leading designer and manufacturer of Light-Sport, Experimental, and Part 23 Certified backcountry aircraft, looks to take advantage of Regulation A. This will allow new public investment to take the company to the next level, increasing manufacturing capacity and accelerating innovation.

Cub Crafters Inc. (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (STC) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (FAA) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility.

The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (FAA) type certified in December 2004. The Top Cub was also granted type certificates (TC) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (LSA) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S.

CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments.

CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft.

Aircraft

The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying.

The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard.

The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018.

CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming.

In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub.

Market Overview

According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel.

CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market.

Management Team

Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees.

Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees.

Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University.

Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide.

Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design.


Recent News

chart

QSAM Biosciences Inc. (OTCQB: QSAM)

The QualityStocks Daily Newsletter would like to spotlight QSAM Biosciences Inc. (OTCQB: QSAM).

New research has identified a molecule that is involved in both cardiovascular disease and cancer metastasis. For cancer to become malignant, cells in tumors undergo various transformations that involve interactions between the tumor and an individual’s immune system. While most of the details involved in this process are unclear, evidence has shown that endothelial cell inflammation plays a key role in a tumor’s progression to metastasis. Endothelial cells usually form a layer lining the blood vessels in the body, helping regulate exchanges between the bloodstream and surrounding tissue. Many more entities, including QSAM Biosciences Inc. (OTCQB: QSAM), are engaged in cancer research, and the future looks bright because more effective treatments are being developed based on the new discoveries about how tumors form and spread.

QSAM Biosciences Inc. (OTCQB: QSAM) is a clinical stage biotechnology company focused on bringing to market targeted therapeutic radiopharmaceuticals. The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients.

QSAM Biosciences was founded in 2020 by Executive Chairman Dr. C. Richard Piazza and CEO Douglas Baum. It is headquartered in Austin, Texas.

CycloSam®

CycloSam®, QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. By leveraging a patented, low specific activity form of Samarium-153 (resulting in far less undesirable europium impurity) and what management believes to be a superior chelating agent in DOTMP, CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the bone tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters are currently being tested in an FDA-cleared clinical trial.

CycloSam® has been shown in laboratory testing to cause significantly less (30x less) buildup of long-lived radionuclidic impurities than prior FDA-approved drugs, which management believes will enable the ability to safely administer therapeutic doses via higher and multiple-dose regimens and effectively expand its potential clinical utility to therapeutic uses in areas of high unmet medical needs.

The indications for CycloSam® currently being evaluated by QSAM Biosciences include:

  • Metastatic Bone Cancers – On April 28, 2022, QSAM Biosciences announced that the first patient had commenced treatment in its clinical trial evaluating CycloSam in patients with metastatic bone cancer. As noted in the release, the study is a Phase 1 open-label, dose-escalation trial to evaluate the safety, tolerability, dosimetry, and preliminary efficacy of CycloSam®.
  • Pediatric Osteosarcoma/Ewing’s Sarcoma – On February 2, 2022, the company announced that the U.S. FDA has granted Rare Pediatric Disease Designation to CycloSam for the treatment of osteosarcoma. Combined with a previously granted orphan drug designation for osteosarcoma received in 2021, this milestone “may allow QSAM to potentially bring CycloSam® to market more rapidly through additional incentives and eligibilities,” according to CEO Douglas Baum.
  • Bone Marrow Ablation – In a 2020 single patient Investigational New Drug (IND) study, an investigator concluded that high-dose CycloSam® can be administered safely to ablate bone marrow in advance of a stem cell transplant with no apparent renal toxicity and no unexpected adverse events attributable to the drug.

QSAM Biosciences’ preclinical and clinical development pipeline is supported by a strong IP portfolio. The company has secured 14 patents across three distinct patent families spanning the U.S., Japan, Canada and the European Union.

Market Outlook

Through its ongoing development of CycloSam®, QSAM Biosciences is targeting multiple large and underserved market opportunities. According to the American Cancer Society, roughly 400,000 new cases of malignant bone metastasis are diagnosed annually in the U.S. alone. Additionally, QSAM will pursue indications for osteosarcoma and Ewing’s sarcoma that are the most common primary malignancies of bone tissues in children.

Despite this pressing need, the current standard of care for bone cancer is aggressive and suboptimal, leading to marginal success with significant side effects and poor long-term survival prognosis. As a result, QSAM Biosciences estimates a sizable market opportunity for its development pipeline.

  • Bone Metastasis has an estimated total addressable market of $20 billion in the U.S. based on total new cases and comparable drug pricing.
  • Osteosarcoma/Ewing’s Sarcoma have a total addressable market of roughly $125 million in the U.S. based on approximately 1,000 new cases in 2021.
  • The total addressable market for Bone Marrow Ablation is projected at $1 billion, with an estimated 32,000 procedures completed annually.

The company anticipates that the ability to administer CycloSam® for higher and multiple-dose regimens may expand its clinical utility for therapeutic uses in additional areas of high unmet medical needs.

Management Team

QSAM Biosciences is led by an experienced management team and board with an extensive record of FDA approvals, big pharma partnerships and M&A transactions.

Dr. C. Richard Piazza is the Executive Chairman of QSAM Biosciences. Since 2017, he has also served as President and CEO of IGL Pharma Inc., the licensor of CycloSam®, and as a consultant to IsoTherapeutics Group LLC, the inventors of the technology. Dr. Piazza also currently serves on the board of directors of NovaScan LLC, a privately held cancer detection and diagnostics company. He has more than 48 years of health care experience in both medical devices and pharmaceutical/biotech and has led several technology companies to market success, including numerous FDA approvals in both sectors. Dr. Piazza obtained a BS in Economics and a BS in Speech Pathology from the State University of New York and an MA & PhD in Economics from the University of Buffalo and Leeds University.

Douglas R. Baum is the company’s CEO and Director. He brings to QSAM Biosciences over 30 years of experience in the bioscience and biotech industries, including development, FDA/EMA approval and commercialization of multiple drugs and medical devices. Mr. Baum has overseen 15 product approvals through the FDA and EMA and raised over $85 million in capital to fund breakthrough technologies. From 2017 to 2020, he consulted with multiple medical schools and biotech and pharmaceutical companies, and, from 2012 to 2017, he served as President, Chief Executive Officer and Director of Xeris Pharmaceuticals Inc. Mr. Baum holds a Master of Science in Technology Commercialization and a BBA in International Business and Marketing from the University of Texas.

Adam King is the CFO of QSAM Biosciences. He is also the Founder and CEO of King Consulting Group, where he provides a range of financial and reporting services for clients. Before founding King Consulting Group in January 2021, Mr. King was the CFO for Netsertive, a venture-backed digital marketing company. From 2016 to 2018, he was the Office Managing Audit Director for BDO’s Greenville, South Carolina, office, in addition to serving as Audit Director in Raleigh, North Carolina, and Boston, Massachusetts. While at BDO, Mr. King worked with various clients, from tech and life science start-ups to billion-dollar publicly traded companies. He holds a Bachelor of Science in Accounting from Elon University and is a CPA in Raleigh, North Carolina.

QSAM Biosciences Inc. (OTCQB: QSAM), closed Monday's trading session at $5.0787, even for the day. The average volume for the last 3 months is 25 and the stock's 52-week low/high is $3.50/$20.40.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) recently finalized the payment of $840,000, the last installment fulfilling all outstanding obligations toward the acquisition of Sapientia Technology LLC. “According to the company’s management, completing this milestone allows Sapientia to further collaborate with other Eat Well portfolio companies to increase its margins and expand its product lines and flavors. Since its acquisition, Sapientia has remained committed to becoming an industry leader in the snack market. It has created and filed four foundational patents revolving around the ‘Protein Twist’ and crispy puff style snack, capitalizing on the initial success of the protein curls. In addition, the company has also launched a pilot program in Federated Co-op western Canada, evaluated multiple-tiered manufacturing solutions to scale the core product, and refined the business development pipeline for private labeling,” a recent article reads. “Sapientia continues to develop an e-commerce pilot program via Amazon U.S. for the second half of 2022 and plans to increase its store count in the third quarter of this fiscal year. Its management believes that maintaining the current momentum will allow the company to meet new demand while ultimately creating value for its shareholders.” To view the full article, visit https://ibn.fm/q1Z7V

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.

Portfolio

On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Monday's trading session at $0.17224, even for the day. The average volume for the last 3 months is 11,010 and the stock's 52-week low/high is $0.13158/$1.00.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

Friendable (OTC: FDBL) released the Fan Pass Live artist platform in July 2020. “Fan Pass Live allows independent artists to perform for and interact with fans without label control or costs. In January 2022, Friendable completed the acquisition of Artist Republik and FeaturedX to create the ultimate ‘anti-label,’ 360-degree solution for independent artists… With Artist Republik, artists can distribute their music, keep 100% of the royalties, and keep the rights to the music they produce. Artists receive royalty payouts quarterly, accessible through their Distribution Dashboard on the app. Artists are also afforded the opportunity to distribute and grow via Spotify and Soundcloud,” a recent article reads. “Fan Pass Live offers independent artists: scheduled events promoted on the company’s social media platforms; five different avenues for collecting revenue; access to advanced analytics; custom merchandise and design; [and] 100% revenue from livestream performance. The 360-degree artists offering provides the tools for independent artists to reclaim their music, make money and connect with fans worldwide.” To view the full article, visit https://ibn.fm/aWrEx

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Monday's trading session at $0.0002, even for the day, on 111,807,740 volume. The average volume for the last 3 months is 101.808M and the stock's 52-week low/high is $0.00015/$0.018.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

  • Denver Post op-ed piece reports no evidence that tailings cells are leaking or contaminating groundwater
  • U.S. goal to cut emissions in half calls for greater support, investment in domestic manufacturing of clean-energy technologies
  • Communicating correct facts can help others recognize that White Mesa Mill is not a threatening or dangerous neighbor

After concerns surfaced about the impact a Utah uranium mill might have on the surrounding water sources, an op-ed piece in the Denver Post reported that there is “no evidence that implies the tailings cells are leaking or contaminating groundwater” (https://ibn.fm/4ZfQT). That assessment aligns with what Energy Fuels (NYSE American: UUUU) (TSX: EFR) has said all along; safety and environmental protection are top priorities for the company, which is a leading U.S. producer of uranium and vanadium, and an emerging producer of rare earth element (“REE”) products.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Monday's trading session at $6.52, off by 2.8316%, on 2,154,311 volume. The average volume for the last 3 months is 2.066M and the stock's 52-week low/high is $4.32/$11.39.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence across automotive and smart infrastructure markets. Han joined Cepton in 2016 and has served as both vice president and senior vice president of operations, where he has led product development, commercialization and operational excellence teams; in those roles he has been pivotal in helping Cepton meet key milestones and expand engagements with the top- 10 automakers in the world. “As one of Cepton’s founding members and a key contributor to the productization and development of MMT lidars, Liqun has demonstrated outstanding leadership in driving operational excellence,” said Cepton Technologies CEO and cofounder Dr. Jun Pei in the press release. “Liqun has played a pivotal role in enabling Cepton’s leap from a lidar technology innovator to an OEM-validated provider of lidar solutions in just a few years. As we continue to expand collaboration with leading OEM customers, tier 1 partners and manufacturing partners, we look forward to Liqun’s continued leadership.” To view the full press release, visit https://ibn.fm/lEyLB

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Monday's trading session at $1.46, off by 0.680272%, on 107,840 volume. The average volume for the last 3 months is 107,290 and the stock's 52-week low/high is $1.01/$80.16.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

  • FingerMotion is an evolving technology company that aims to improve people’s lifestyles through technology and innovative products and services
  • The company recently launched mobile device protection products in partnership with a Fortune 500 insurance company and major Chinese telcos
  • The products will offer three tiers of protection: accidental damage to screens, mechanical breakdown, and trade-in solutions
  • FingerMotion has taken a strategic approach to launching the products as it targets a burgeoning market set to be valued at about $12n.2 billion by 2028 

Evolving technology company FingerMotion (NASDAQ: FNGR) recently demonstrated the flexibility of its business model that affords it even more ways to monetize its vast active user base when its subsidiary, Shanghai TengLian Jiujiu Information and Communication Technology Co. Ltd (“TengLian”), launched the mobile device protection products (https://ibn.fm/ejdH6). The launch casts in stone a cooperation agreement entered in February this year between TengLian and two of China’s largest telecom operators, China Unicom and China Mobile (https://ibn.fm/Jh3VX).

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Monday's trading session at $1.17, off by 1.6807%, on 45,707 volume. The average volume for the last 3 months is 45,707 and the stock's 52-week low/high is $1.08/$9.25.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

In 2021 alone, states with legal cannabis markets collected more than $3.7 billion in recreational cannabis taxes. Michigan, which legalized adult-use cannabis in 2018, collected almost $175 million from a 10% excise tax on all recreational cannabis sales in the same year. Regulators from the state recently announced that a portion of these funds would be funneled to institutions researching the potential medical benefits of cannabis for veterans. This will be the second round of funding provided by the Michigan Cannabis Regulatory Agency (MRA) as part of the state’s Veteran Marijuana Research (VMR) Grant Program. This time, the agency will recommend providing two universities with $20 million in grants. According to Michigan’s recreational cannabis law, the state has to provide nonprofit organizations or academic institutions with $20 million annually. The marijuana tax funds being injected by Michigan into studying how cannabis can be helpful to military veterans illustrates just how far-reaching the benefits of permitting companies such as Flora Growth Corp. (NASDAQ: FLGC) to operate can be, not just to the economy but to the community as well.

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.

Cultivation

Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Monday's trading session at $0.6293, off by 1.1933%, on 228,650 volume. The average volume for the last 3 months is 228,650 and the stock's 52-week low/high is $0.586/$21.45.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.